Portal de Periódicos da CAPES

The British Journal of Haematology in 2020

2020; Wiley; Volume: 188; Issue: 2 Linguagem: Inglês

10.1111/bjh.16516

1365-2141

John Barrett,

Myeloproliferative Neoplasms: Diagnosis and Treatment

It is 65 years since the British Journal of Haematology was launched. Over the years BJHaem has been a faithful mirror of transformational developments in our field which have brought new understanding of disease processes and curative treatments for hitherto lethal malignant and non-malignant conditions. In the process the journal has changed and grown in its coverage of all aspects of clinical and laboratory haematology. It has become an international journal with an international readership. It publishes more papers from outside the UK than from within while remaining closely allied to the British Society for Haematology. The fast pace of change both within the science and clinical practice of haematology and in the way information is disseminated requires BJHaem to be flexible and adapt to the times to maintain and improve its value to a worldwide community. Furthermore faced with increasing submission rates (now over 2500 manuscript submissions a year) the limited page space for the journal despite two issues a month mean that there is not room for all the good papers worthy of publication. The launch in November 2019 of our on line open access sister journal eJHaem under the direction of its editor Andrew Evens will mitigate these restrictions as well as providing a fresh new voice in the ever expanding haematological field. To increase its appeal and maintain a contemporary look we are also bringing changes to the BJH. Starting with a new cover design (shared with eJHaem to emphasize our connectivity) we will include a cover figure selected from the issue contents both for its scientific or clinical impact as well as its artistic qualities. Inside, look for a new table of contents with sections that reflect contemporaneous areas of activity. For example we now have a section specifically for the haemoglobinopathies, and the large section on haematological malignancies has been broken down into “Clinical” and “Biological” sections. In the past Editorial Commentaries have highlighted one or sometimes two key papers from that issue. We are renaming the section Commentaries, shortening each contribution, but extending the number of papers selected to highlight up to five key papers. There are two new occasional sections “Emergencies in Haematology” solicited expert reviews on the management of life-threatening events, and “The Wider Perspective” where we seek to have a global reach through solicited comparisons and accounts of clinical practice worldwide, historical accounts and aspects not usually covered by standard reviews but of general interest to haematologists worldwide. Despite the trend to on-line publishing in the infinite virtual cloud, page space still regulates issue contents. The current Harvard reference style is not only cumbersome for authors to generate but also expensive in page space. For these reasons we are moving to the widely used Vancouver reference style. Thinner issues have lower distribution costs and savings can be transmitted to other areas of publishing such as innovative on-line content (eg videos from authors to add perspective to their papers). Watch over the next few months for the phasing out of the Harvard notation and the introduction of Vancouver and you will easily perceive how much space can be saved in this way.